Related Experiment Video
Updated: Aug 18, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Grb7-SH2 domain dimerisation is affected by a single point mutation
Corrine J Porter1, Matthew C J Wilce, Joel P Mackay
1School of Biomedical and Chemical Sciences, University of Western Australia, 35 Stirling Highway, Crawley, Perth, WA 6009, Australia.
Abstract:
Growth factor receptor bound protein 7 (Grb7) is an adaptor protein that is co-overexpressed and forms a tight complex with the ErbB2 receptor in a number of breast tumours and breast cancer cell lines. The interaction of Grb7 with the ErbB2 receptor is mediated via its Src homology 2 (SH2) domain. Whilst most SH2 domains exist as monomers, recently reported studies have suggested that the Grb7-SH2 domain exists as a homodimer. The self-association properties of the Grb7-SH2 domain were therefore studied using sedimentation equilibrium ultracentrifugation. Analysis of the data demonstrated that the Grb7-SH2 domain is dimeric with a dissociation constant of approximately 11 muM. We also demonstrate, using size-exclusion chromatography, that mutation of phenylalanine 511 to an arginine produces a monomeric form of the Grb7-SH2 domain. This mutation represents the first step in the engineering of a Grb7-SH2 domain with good solution properties for further biophysical and structural investigation.
Insights
Growth factor receptor bound protein 7 (Grb7) is an adaptor protein implicated in breast cancer. The Grb7 Src homology 2 (SH2) domain, crucial for ErbB2 interaction, was found to be dimeric, a property that can be disrupted by specific mutations.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Growth factor receptor bound protein 7 (Grb7) is an adaptor protein.
- Grb7 is co-overexpressed with the ErbB2 receptor in breast tumors.
- The interaction between Grb7 and ErbB2 is mediated by the Grb7 Src homology 2 (SH2) domain.
Purpose of the Study:
- To investigate the self-association properties of the Grb7-SH2 domain.
- To determine if the Grb7-SH2 domain exists as a monomer or dimer.
- To identify mutations that alter the oligomeric state of the Grb7-SH2 domain for biophysical studies.
Main Methods:
- Sedimentation equilibrium ultracentrifugation to assess protein oligomerization.
- Size-exclusion chromatography to analyze the effect of mutations on protein structure.
- Site-directed mutagenesis to alter specific amino acid residues.
Main Results:
- The Grb7-SH2 domain was confirmed to exist as a homodimer in solution.
- A dissociation constant (Kd) of approximately 11 μM was determined for the Grb7-SH2 domain dimer.
- Mutation of phenylalanine 511 to arginine resulted in a monomeric form of the Grb7-SH2 domain.
Conclusions:
- The Grb7-SH2 domain exhibits self-association, existing as a dimer.
- Specific mutations, such as F511R, can disrupt dimerization and yield a monomeric Grb7-SH2 domain.
- This engineered monomeric Grb7-SH2 domain is a valuable tool for future biophysical and structural investigations.
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Point and Frameshift Mutations
Conservation of Protein Domains Over Different Proteins
A limited set of protein domains often duplicate and recombine during evolution. These domains can be organized in different combinations to form...
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
Mutations
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
